In an unusual outbreak of measles in San Diego, 12 children fell ill; nine of them had not been inoculated against the virus because their parents objected.
Link to Article
NYTimes.com
|
|
||||
|
This Month
Month Archive
RSS Newsfeeds
Main Page RSS
|
Saturday, March 22
Public Health Risk Seen as Parents Reject Vaccines
by
Alex Hsieh on behalf of Professor Henry Wang
on Sat 22 Mar 2008 11:19 PM EDT
New Rheumatoid Arthritis Drug Works for Adults, Children
by
Lyle
on Sat 22 Mar 2008 11:30 AM EDT
GEN News Highlights - 3/24/08
by
Lyle
on Sat 22 Mar 2008 11:27 AM EDT
Link to All Articles
Mar 20 2008, 12:43 PM EST Takeda Could Shell Out up to $1.5B in Dissolution of Joint Venture with Abbott Abbott also gains prostate cancer drug, while Takeda keeps peptic ulcer treatment and investigational pipeline.Full Story Mar 20 2008, 12:36 PM EST Presidio Buys Rights to XTL's Preclinical HCV Program for $4M Upfront XTL could receive $104 million upon certain development and commercialization successes.Full Story Mar 20 2008, 12:38 PM EST Role for Insulin in Lifespan Discovered Study published in Cell shows that the hormone inhibits a master gene regulator protein of the Phase 2 detoxification pathway.Full Story Mar 19 2008, 12:54 PM EST AstraZeneca Taps Cenix for RNAi Drug Discovery Cenix will initially focus on finding and validating oncology targets as well as developing a related RNAi dataset.Full Story Mar 19 2008, 12:55 PM EST Alkermes Prompted to Restructure with Eli Lilly's Decision to Drop Inhaled Insulin Development Company is letting go of 18% of its employees, shutting down its MA plant, and could endure up to $25 million in charges.Full Story Mar 18 2008, 12:48 PM EST Immune Response Protein Shifts between Two Unrelated Structures Study in PNAS shows that each shape has a unique role in attracting and activating white blood cells.Full Story Mar 18 2008, 12:41 PM EST Prometic Inks Deal with Sartorius Stedim Biotech to Buttress Asian Business Sartorius Stedim Biotech has become the preferred equipment supplier to ProMetic's licensees.Full Story Mar 17 2008, 11:51 AM EST Q Therapeutics Selects Goodwin to Manufacture Purification mAb The IgM antibody is used in the production of the firm's cell therapy, which is scheduled to enter a Phase I study in 2009 for transverse myelitis.Full Story Mar 14 2008, 11:40 AM EST Lilly Pays $7M Upfront for Transition's Diabetic Program Worldwide, exclusive licensing deal covering gastrin compounds could yield another $130 million in milestones.Full Story GenEngNews.com
Another company recalls blood thinner heparin
by
Lyle
on Sat 22 Mar 2008 11:26 AM EDT
Alkermes takes AIR Insulin blow with redundancies, facility closure
by
Lyle
on Sat 22 Mar 2008 11:25 AM EDT
20-Mar-2008 - US-based drug delivery specialist Alkermes is cutting its losses following Eli Lilly's decision to scrap the companies' joint development programme for inhaled insulin.
Link to Article In-Pharmatechnologist.com
Public Health Risk Seen as Parents Reject Vaccines
by
Lyle
on Sat 22 Mar 2008 11:24 AM EDT
In an unusual outbreak of measles in San Diego, 12 children fell ill; nine of them had not been inoculated against the virus because their parents objected.
Link to Article NYTimes.com
FDA Clarifies Its Role in Heparin Investigations
by
Lyle
on Sat 22 Mar 2008 11:22 AM EDT
Rockville, MD (Mar. 14)—Hoping to provide a better understanding of its role in the heparin contamination investigations, the US Food and Drug Administration has posted a series of information sheets on its website. The three documents review the agency’s role in analyzing reports of adverse reactions, collecting and testing contamination samples, and implementing “import alert” systems for shipments from specified manufacturers.
Link to Article Pharmaceutical Technology |
Search
Links
|
||